Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Dig Dis

Retrieve available abstracts of 38 articles:
HTML format



Single Articles


    May 2024
  1. CAPPUCCIO JM, Mehta N, Pellish R
    Inpatient Infliximab Biosimilar Cost-Savings - Cost analysis of inpatient treatment with originator Infliximab (Remicade) vs biosimilar Infliximab (Renflexis) for acute severe ulcerative colitis.?.
    Dig Dis. 2024 May 24. doi: 10.1159/000536303.
    PubMed     Abstract available


    March 2024
  2. GUERRA I, Barros F, Chaparro M, Benitez JM, et al
    Evaluation of genetic variants associated with the risk of thiopurine-related pancreatitis: a case control study from ENEIDA registry.
    Dig Dis. 2024 Mar 7. doi: 10.1159/000537782.
    PubMed     Abstract available


    December 2023
  3. SIGALL BONEH R, Assa A, Lev-Tzion R, Matar M, et al
    Adherence to the Mediterranean diet is associated with decreased Fecal Calprotectin Levels in Children with Crohn's Disease in Clinical Remission under biological Therapy.
    Dig Dis. 2023 Dec 1. doi: 10.1159/000535540.
    PubMed     Abstract available


    September 2023
  4. YANG MM, Usiskin K, Ahmad HA, Ather S, et al
    Considerations for Colorectal Neoplasia Detection in Inflammatory Bowel Disease Clinical Trials.
    Dig Dis. 2023 Sep 27. doi: 10.1159/000533395.
    PubMed     Abstract available


  5. BOLDOVJAKOVA D, El-Abbassy I, Alarcon I, El-Saify M, et al
    Management of the Rectal Stump after Subtotal Colectomy Operations for Inflammatory Bowel Disease in the Era of Immunologic Therapy: A Two-Centre Cohort Study.
    Dig Dis. 2023 Sep 8:1-7. doi: 10.1159/000533267.
    PubMed     Abstract available


    August 2023
  6. BASTIDA PAZ G, Merino Ochoa O, Aguas Peris M, Barreiro-de Acosta M, et al
    The Risk of Developing Disabling Crohn's Disease: Validation of a Clinical Prediction Rule to Improve Treatment Decision Making.
    Dig Dis. 2023 Aug 23:1-11. doi: 10.1159/000531789.
    PubMed     Abstract available


    June 2023
  7. NERI B, Russo C, Mossa M, Martire FG, et al
    High Frequency of Deep Infiltrating Endometriosis in Patients with Inflammatory Bowel Disease: A Nested Case-Control Study.
    Dig Dis. 2023 Jun 30:1. doi: 10.1159/000530896.
    PubMed     Abstract available


  8. SURDEA-BLAGA T, Ismaiel A, Jaaouani A, Leucuta DC, et al
    Adiponectin Levels in Inflammatory Bowel Disease - A Systematic Review and Meta-analysis.
    Dig Dis. 2023 Jun 29. doi: 10.1159/000531614.
    PubMed     Abstract available


  9. SHI H, Zeng H, Wang M, Jiang J, et al
    Effectiveness of water-assisted colonoscopy without sedation in patients with ulcerative colitis.
    Dig Dis. 2023 Jun 27. doi: 10.1159/000531652.
    PubMed     Abstract available


    March 2023
  10. SALEH A, Parsa S, Garza M, Quigley EMM, et al
    The Role of Fecal Microbiota Transplantation in the Induction of Remission in Ulcerative Colitis.
    Dig Dis. 2023 Mar 1. doi: 10.1159/000529591.
    PubMed     Abstract available


    January 2023
  11. BARAJAS ORDONEZ F, Melekh B, Rodriguez-Feria P, Melekh O, et al
    Body composition predictors of complicated Crohn's disease.
    Dig Dis. 2023 Jan 31. doi: 10.1159/000529426.
    PubMed     Abstract available


  12. RAMOS L, Reygosa C, Carrillo-Palau M, Alonso-Abreu I, et al
    EFFICACY, EFFICIENCY, AND ACCEPTABILITY OF TELEMEDICINE FOR INFLAMMATORY BOWEL DISEASE PATIENTS FOLLOW-UP CARE DURING THE COVID-19 PANDEMIC.
    Dig Dis. 2023 Jan 30. doi: 10.1159/000529106.
    PubMed     Abstract available


  13. HILMI IN, Nik Muhammad Affendi NA, Shahrani S, Thalha AM, et al
    High accuracy of a simplified, practical algorithm in differentiating Crohn's Disease from Intestinal Tuberculosis.
    Dig Dis. 2023 Jan 26. doi: 10.1159/000529238.
    PubMed     Abstract available


  14. DUBINSKY MC, Armuzzi A, Gecse KB, Ullman T, et al
    Improvements in disease activity partially mediate the effect of tofacitinib treatment on generic and disease-specific health-related quality of life in patients with ulcerative colitis: data from the OCTAVE program.
    Dig Dis. 2023 Jan 5. doi: 10.1159/000528788.
    PubMed     Abstract available


  15. HELWIG U, Krause TH, Maaser C, Buning J, et al
    Early MOnitoring of REsponse (MORE) to Golimumab Therapy: Results of a Multicentre, Prospective Observational Trial.
    Dig Dis. 2023;41:239-249.
    PubMed     Abstract available


  16. PELEG N, Yanai H, Gingold-Belfer R, Dotan I, et al
    Video Capsule Endoscopy after Bariatric Surgery: A Tertiary Referral Center Experience.
    Dig Dis. 2023;41:233-238.
    PubMed     Abstract available


  17. KRAL J, Nakov R, Lanska V, Barberio B, et al
    Significant Differences in IBD Care and Education across Europe: Results of the Pan-European VIPER Survey.
    Dig Dis. 2023;41:387-395.
    PubMed     Abstract available


    December 2022
  18. VAN DEEN WK, Khalil C, Bonthala NN, Gale R, et al
    Inflammatory Bowel Disease Patients' Preferences for Subcutaneous Versus Intravenous Therapies: A Mixed Methods Study.
    Dig Dis. 2022 Dec 7. doi: 10.1159/000528586.
    PubMed     Abstract available


  19. YOU L, Bai C, Wang S, Yu X, et al
    The prevalence and factors that impact frailty in Inflammatory Bowel disease patients hospitalized in a tertiary hospital in China.
    Dig Dis. 2022 Dec 1. doi: 10.1159/000528459.
    PubMed     Abstract available


    January 2022
  20. FADEN H
    The Role of Faecalibacterium, Roseburia and Butyrate in Inflammatory Bowel Disease.
    Dig Dis. 2022 Jan 27. pii: 000522247. doi: 10.1159/000522247.
    PubMed     Abstract available


  21. MIYAZAKI R, Sakurai T, Iwashita Y, Shimada M, et al
    Characteristics and Endoscopic Classification of Ulcerative Lesions Affecting the Ileocecal Valve.
    Dig Dis. 2022;40:239-245.
    PubMed     Abstract available


  22. CHEN F, Dai Z, Huang C, Chen H, et al
    Gastrointestinal Disease and COVID-19: A Review of Current Evidence.
    Dig Dis. 2022;40:506-514.
    PubMed     Abstract available


    December 2021
  23. FERRARESE D, Spagnolo G, Vecchione M, Scaldaferri F, et al
    Signs of dissociation and symptoms of post-traumatic stress disorder in inflammatory bowel disease. A case-control study.
    Dig Dis. 2021 Dec 17. pii: 000521424. doi: 10.1159/000521424.
    PubMed     Abstract available


  24. CLASSEN JM, Muzalyova A, Nagl S, Fleischmann C, et al
    Antibody response to SARS-CoV-2 vaccination in patients with inflammatory bowel disease - results of a single-center cohort study in a tertiary hospital in Germany.
    Dig Dis. 2021 Dec 10. pii: 000521343. doi: 10.1159/000521343.
    PubMed     Abstract available


  25. LONG MD, Cohen RD, Smith TW, DiBonaventura M, et al
    Retrospective Database Analysis: Dose Escalation and Adherence in Patients Initiating Biologics for Ulcerative Colitis.
    Dig Dis. 2021 Dec 8. pii: 000521299. doi: 10.1159/000521299.
    PubMed     Abstract available


    February 2021
  26. SORRENTINO D, Nguyen VQ, Love K
    Fecal lactoferrin predicts primary non-response to biologic agents in inflammatory bowel disease.
    Dig Dis. 2021 Feb 25. pii: 000515432. doi: 10.1159/000515432.
    PubMed     Abstract available


  27. LEAL T, Goncalves M, Antunes P, Costa D, et al
    Sleep disturbance in Inflammatory Bowel Disease is associated with disease activity and adverse outcome.
    Dig Dis. 2021 Feb 15. pii: 000515218. doi: 10.1159/000515218.
    PubMed     Abstract available


    January 2021
  28. STREMMEL W, Vural H, Evliyaoglu O, Weiskirchen R, et al
    Delayed Release Phosphatidylcholine is Effective for Treatment of Ulcerative Colitis: A Meta-Analysis.
    Dig Dis. 2021 Jan 13. pii: 000514355. doi: 10.1159/000514355.
    PubMed     Abstract available


  29. MATEOS B, Saez-Gonzalez E, Moret I, Hervas D, et al
    Plasma Oncostatin M, TNF-alpha, IL-7, and IL-13 Network Predicts Crohn's Disease Response to Infliximab, as Assessed by Calprotectin Log Drop.
    Dig Dis. 2021;39:1-9.
    PubMed     Abstract available


  30. HUNT RH, East JE, Lanas A, Malfertheiner P, et al
    COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist.
    Dig Dis. 2021;39:119-139.
    PubMed     Abstract available


  31. GRASS F, Zhu E, Brunel C, Hubner M, et al
    Crohn's versus Cancer: Comparison of Functional and Surgical Outcomes after Right-Sided Resections.
    Dig Dis. 2021;39:106-112.
    PubMed     Abstract available


  32. RUEDA GARCIA JL, Suarez-Ferrer C, Poza Cordon J, Martin-Arranz E, et al
    Doppler Activity and Ultrasonographic Detection of Intra-Abdominal Fistulas Are Predictors of Surgery in Crohn's Disease.
    Dig Dis. 2021;39:204-210.
    PubMed     Abstract available


  33. DE SOUSA MAGALHAES R, Xavier S, Curdia Goncalves T, Dias de Castro F, et al
    Does Perianal Disease Influence the Efficacy of Combination Therapy in Crohn's Disease?
    Dig Dis. 2021;39:417-428.
    PubMed     Abstract available


  34. KOSLOWSKY B, Mazuz B, Ben-Ya'acov A, Neumark A, et al
    Gastroenterologists' Attitude Regarding Medical Cannabis for Inflammatory Bowel Diseases in Israel.
    Dig Dis. 2021;39:502-507.
    PubMed     Abstract available


    November 2020
  35. YU T, Meng F, Xie M, Liu H, et al
    LncRNA PMS2L2 downregulates miR-24 through methylation to suppress cell apoptosis in ulcerative colitis.
    Dig Dis. 2020 Nov 25. pii: 000513330. doi: 10.1159/000513330.
    PubMed     Abstract available


    January 2020
  36. REISCHL S, Troger J, Jesinghaus M, Kasajima A, et al
    Annexin A1 Expression Capacity as a Determinant for Disease Severity in Crohn's Disease.
    Dig Dis. 2020;38:398-407.
    PubMed     Abstract available


  37. KANI HT, Sakalli Kani A, Dural U, Basgoze E, et al
    The Effect of Dream Anxiety on Sleep Quality in Inflammatory Bowel Diseases.
    Dig Dis. 2020;38:380-389.
    PubMed     Abstract available


  38. LU R, Kassim T, Dave D, Klair JS, et al
    Diagnostic Yield of Colonoscopy in Young Adults with Lower Gastrointestinal Symptoms in a Multicenter Midwest Cohort.
    Dig Dis. 2020;38:484-489.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.